Novo Nordisk has cut its cell therapy division, where it was trying to find a cure for type 1 diabetes, Bloomberg News ...

Markets have had an uncertain week, pulled in different directions by AI demand hopes and US government shutdown worries.

() -Johnson & Johnson is in discussions to buy Protagonist Therapeutics, a source familiar with the matter told . Shares of ...

OTTAWA (Reuters) -Reviving the proposed Keystone XL oil pipeline from Alberta to the U.S. could play a part in tightening U.S ...

Wall Street is looking to U. drugmaker Eli Lilly and Anglo-Swedish rival AstraZeneca as the potential next in line after ...

A monthslong calm on Wall Street is shattering Friday, and U.S. stocks are falling after President Donald Trump threatened to ...

U.S. President Donald Trump threatened to hike tariffs against China and cancel a planned meeting with President Xi Jinping, ...

Brazil's government on Friday announced a new real estate funding framework that loosens rules on the mandatory allocation of ...

Big Tech heavy hitters will report their third quarter earnings in the coming October weeks, which will give Wall Street a ...

The IRS has announced several updates that will impact how Americans file their taxes over the next two years.

While details about the pact weren’t immediately clear, the accord stems from a major push to lower drug prices in the US and ...

The dollar dropped on Friday after U.S. President Donald Trump threatened to hike tariffs against China, reigniting concerns ...